Cargando…

The regulatory control of Cebpa enhancers and silencers in the myeloid and red-blood cell lineages

Cebpa encodes a transcription factor (TF) that plays an instructive role in the development of multiple myeloid lineages. The expression of Cebpa itself is finely modulated, as Cebpa is expressed at high and intermediate levels in neutrophils and macrophages respectively and downregulated in non-mye...

Descripción completa

Detalles Bibliográficos
Autores principales: Repele, Andrea, Krueger, Shawn, Bhattacharyya, Tapas, Tuineau, Michelle Y., Manu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557489/
https://www.ncbi.nlm.nih.gov/pubmed/31181110
http://dx.doi.org/10.1371/journal.pone.0217580
_version_ 1783425457142628352
author Repele, Andrea
Krueger, Shawn
Bhattacharyya, Tapas
Tuineau, Michelle Y.
Manu,
author_facet Repele, Andrea
Krueger, Shawn
Bhattacharyya, Tapas
Tuineau, Michelle Y.
Manu,
author_sort Repele, Andrea
collection PubMed
description Cebpa encodes a transcription factor (TF) that plays an instructive role in the development of multiple myeloid lineages. The expression of Cebpa itself is finely modulated, as Cebpa is expressed at high and intermediate levels in neutrophils and macrophages respectively and downregulated in non-myeloid lineages. The cis-regulatory logic underlying the lineage-specific modulation of Cebpa’s expression level is yet to be fully characterized. Previously, we had identified 6 new cis-regulatory modules (CRMs) in a 78kb region surrounding Cebpa. We had also inferred the TFs that regulate each CRM by fitting a sequence-based thermodynamic model to a comprehensive reporter activity dataset. Here, we report the cis-regulatory logic of Cebpa CRMs at the resolution of individual binding sites. We tested the binding sites and functional roles of inferred TFs by designing and constructing mutated CRMs and comparing theoretical predictions of their activity against empirical measurements in a myeloid cell line. The enhancers were confirmed to be activated by combinations of PU.1, C/EBP family TFs, Egr1, and Gfi1 as predicted by the model. We show that silencers repress the activity of the proximal promoter in a dominant manner in G1ME cells, which are derived from the red-blood cell lineage. Dominant repression in G1ME cells can be traced to binding sites for GATA and Myb, a motif shared by all of the silencers. Finally, we demonstrate that GATA and Myb act redundantly to silence the proximal promoter. These results indicate that dominant repression is a novel mechanism for resolving hematopoietic lineages. Furthermore, Cebpa has a fail-safe cis-regulatory architecture, featuring several functionally similar CRMs, each of which contains redundant binding sites for multiple TFs. Lastly, by experimentally demonstrating the predictive ability of our sequence-based thermodynamic model, this work highlights the utility of this computational approach for understanding mammalian gene regulation.
format Online
Article
Text
id pubmed-6557489
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-65574892019-06-17 The regulatory control of Cebpa enhancers and silencers in the myeloid and red-blood cell lineages Repele, Andrea Krueger, Shawn Bhattacharyya, Tapas Tuineau, Michelle Y. Manu, PLoS One Research Article Cebpa encodes a transcription factor (TF) that plays an instructive role in the development of multiple myeloid lineages. The expression of Cebpa itself is finely modulated, as Cebpa is expressed at high and intermediate levels in neutrophils and macrophages respectively and downregulated in non-myeloid lineages. The cis-regulatory logic underlying the lineage-specific modulation of Cebpa’s expression level is yet to be fully characterized. Previously, we had identified 6 new cis-regulatory modules (CRMs) in a 78kb region surrounding Cebpa. We had also inferred the TFs that regulate each CRM by fitting a sequence-based thermodynamic model to a comprehensive reporter activity dataset. Here, we report the cis-regulatory logic of Cebpa CRMs at the resolution of individual binding sites. We tested the binding sites and functional roles of inferred TFs by designing and constructing mutated CRMs and comparing theoretical predictions of their activity against empirical measurements in a myeloid cell line. The enhancers were confirmed to be activated by combinations of PU.1, C/EBP family TFs, Egr1, and Gfi1 as predicted by the model. We show that silencers repress the activity of the proximal promoter in a dominant manner in G1ME cells, which are derived from the red-blood cell lineage. Dominant repression in G1ME cells can be traced to binding sites for GATA and Myb, a motif shared by all of the silencers. Finally, we demonstrate that GATA and Myb act redundantly to silence the proximal promoter. These results indicate that dominant repression is a novel mechanism for resolving hematopoietic lineages. Furthermore, Cebpa has a fail-safe cis-regulatory architecture, featuring several functionally similar CRMs, each of which contains redundant binding sites for multiple TFs. Lastly, by experimentally demonstrating the predictive ability of our sequence-based thermodynamic model, this work highlights the utility of this computational approach for understanding mammalian gene regulation. Public Library of Science 2019-06-10 /pmc/articles/PMC6557489/ /pubmed/31181110 http://dx.doi.org/10.1371/journal.pone.0217580 Text en © 2019 Repele et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Repele, Andrea
Krueger, Shawn
Bhattacharyya, Tapas
Tuineau, Michelle Y.
Manu,
The regulatory control of Cebpa enhancers and silencers in the myeloid and red-blood cell lineages
title The regulatory control of Cebpa enhancers and silencers in the myeloid and red-blood cell lineages
title_full The regulatory control of Cebpa enhancers and silencers in the myeloid and red-blood cell lineages
title_fullStr The regulatory control of Cebpa enhancers and silencers in the myeloid and red-blood cell lineages
title_full_unstemmed The regulatory control of Cebpa enhancers and silencers in the myeloid and red-blood cell lineages
title_short The regulatory control of Cebpa enhancers and silencers in the myeloid and red-blood cell lineages
title_sort regulatory control of cebpa enhancers and silencers in the myeloid and red-blood cell lineages
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557489/
https://www.ncbi.nlm.nih.gov/pubmed/31181110
http://dx.doi.org/10.1371/journal.pone.0217580
work_keys_str_mv AT repeleandrea theregulatorycontrolofcebpaenhancersandsilencersinthemyeloidandredbloodcelllineages
AT kruegershawn theregulatorycontrolofcebpaenhancersandsilencersinthemyeloidandredbloodcelllineages
AT bhattacharyyatapas theregulatorycontrolofcebpaenhancersandsilencersinthemyeloidandredbloodcelllineages
AT tuineaumichelley theregulatorycontrolofcebpaenhancersandsilencersinthemyeloidandredbloodcelllineages
AT manu theregulatorycontrolofcebpaenhancersandsilencersinthemyeloidandredbloodcelllineages
AT repeleandrea regulatorycontrolofcebpaenhancersandsilencersinthemyeloidandredbloodcelllineages
AT kruegershawn regulatorycontrolofcebpaenhancersandsilencersinthemyeloidandredbloodcelllineages
AT bhattacharyyatapas regulatorycontrolofcebpaenhancersandsilencersinthemyeloidandredbloodcelllineages
AT tuineaumichelley regulatorycontrolofcebpaenhancersandsilencersinthemyeloidandredbloodcelllineages
AT manu regulatorycontrolofcebpaenhancersandsilencersinthemyeloidandredbloodcelllineages